“…A wise use of therapeutic strategies halting the cancer angiogenesis must thus take into account the abnormal metabolic microenvironment characterizing a heterogeneous oxygenation [ 161 , 162 ]. Assessing oxygenation in the different layers of tumour pinpoint that there is a progressive increase of nutrient and oxygen levels across the inner depth [ 162 ], thus fueling genomic instability [ 163 ], the cancer progression (PD) [ 16 ], the switch to anaerobic metabolism [ 164 ], as well as the epithelial–mesenchymal transition, metastases [ 165 ], and the induction of cancer “stem cell” phenotype [ 166 ]. Hypoxia is a hallmark of cancer, inducing many abnormalities with prognostic consequences linked to defects in apoptosis and autophagy [ 167 , 168 ] and the resistance to radio-chemotherapy [ 169 , 170 , 171 ] and immunotherapy [ 13 , 172 , 173 ] likewise hamper the cancer aggressive phenotype acquisition, while shaping a pro-angiogenic, inflamed, and immunosuppressive neoplastic ecosystem [ 154 , 174 , 175 ].…”